These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1132043)

  • 1. [Principles of reasonable hemotherapy].
    Dobrý E
    Cesk Pediatr; 1975 Jan; 30(1-2):68-71. PubMed ID: 1132043
    [No Abstract]   [Full Text] [Related]  

  • 2. [Good use of blood transfusions: principal indications for hemotherapy].
    Goudemand M; Bauters F; Parquet-Gernez A
    Lille Med; 1974; 19 Spec No():377-85. PubMed ID: 4437301
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current status of the preparation and use of antihemophilic fractions in France. (Their use in surgery in hemophilia)].
    Ménaché D; Josso F; Steinbuch M; Soulier JP
    Transfusion (Paris); 1966; 9(3):237-44. PubMed ID: 5969559
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the therapy of congenital hemorrhagic diatheses].
    Heene D; Hörder MH; Schultis K
    Med Welt; 1968 May; 20():1315-7. PubMed ID: 5717761
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the effect of fresh blood transfusions and normal human plasma, dried, (single donor, antihemophilic) infusions on hemophilia and hemophilia-like diseases.
    YAMADA S; NAITO R
    Bibl Haematol; 1962; 13():413-6. PubMed ID: 14008762
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemotherapy of hemorrhagic shock].
    Benad G
    Z Arztl Fortbild (Jena); 1972 Apr; 66(8):395-9. PubMed ID: 5046406
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indications for blood derivatives in hemorrhagic syndromes (excluding thrombopenia)].
    REVOL L; CROIZAT P
    Sang; 1956; 27(1):39-59. PubMed ID: 13337104
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of normal human plasma fractions in haemophilia.
    VAN CREVELD S; MASTENBROEK GG
    Nature; 1946 Sep; 158():447. PubMed ID: 20999102
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemotherapy in hemophilia].
    PAVLOVSKY A; MARTINEZ CANAVERI A; ANDINO PAVLOVSKY A
    Dia Med; 1958 Aug; 30():56 passim. PubMed ID: 13586098
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasmapheresis.
    Lingeman RB
    J Indiana State Med Assoc; 1966 Jan; 59(1):40-1. PubMed ID: 5900968
    [No Abstract]   [Full Text] [Related]  

  • 11. The practice of hemotherapy and the regional blood program in Delaware.
    Molthan L
    Del Med J; 1981 Oct; 53(10):509-12. PubMed ID: 7338282
    [No Abstract]   [Full Text] [Related]  

  • 12. [Principles of component hemotherapy].
    Agranenko VA
    Probl Gematol Pereliv Krovi; 1978 Jun; 23(6):3-10. PubMed ID: 674158
    [No Abstract]   [Full Text] [Related]  

  • 13. [Main principles of effective hemotherapy].
    Dobrý E
    Cas Lek Cesk; 1968 Nov; 107(47):1436-8. PubMed ID: 5696569
    [No Abstract]   [Full Text] [Related]  

  • 14. From the Centers for Disease Control and Prevention. Blood safety monitoring among persons with bleeding disorders--United States, May 1998-June 2002.
    JAMA; 2003 Feb; 289(5):541-3. PubMed ID: 12578504
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of hemotherapy in hemorrhages in patients with hemophilia].
    Altybaev UA; Mirzaev ShM
    Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):18-9. PubMed ID: 1273057
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indications and transfusion of coagulation-active blood fractions].
    Mueller-Eckhardt C; Heinrich D; Lasch HG
    Z Prakt Anasth; 1970 Dec; 5(6):401-18. PubMed ID: 4256253
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of inherited coagulation disorders].
    Blombäck M; Nilsson IM
    Lakartidningen; 1972 Dec; 69():Suppl 4:76-84. PubMed ID: 4540328
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemotherapy in hemophilia].
    PAVLOVSKY A; MARTINEZ CANAVERI A; ANDINO A
    Prensa Med Argent; 1958 Jun; 45(26):2377-8. PubMed ID: 13623657
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transfusion of plasma of endotoxin tolerant rats improves survival of hemorrhagic shock in the rat model].
    Reuter M; Bahrami S; Ackermann M; Obertacke U; Schade FU; Schlag G
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):177-80. PubMed ID: 14518237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proceedings: Therapy of hemophilia A and B].
    Mannucci PM
    Minerva Pediatr; 1973 Dec; 25(42):1889-905. PubMed ID: 4359559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.